Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XDHECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XDHECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XDHEHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XDHEHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XDHENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XDHENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.15.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.15.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.15.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FL.15.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FL.15.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FL.15.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.15.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.15.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.2.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
EG.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.2.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
EG.2.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
EG.2.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
EG.2.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EG.2.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.2.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.607EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.607EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.607ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.607ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.607EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.607EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.607ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.607ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.163EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.163EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.163ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.163ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.163EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.163EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.163ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.163ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.337EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.337EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.337ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.337ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.337EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.337EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.337ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.337ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.158EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.158EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.158ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.158ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used